BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
22 results:

  • 1. Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells.
    Siemaszko J; Łacina P; Szymczak D; Szeremet A; Majcherek M; Czyż A; Sobczyk-Kruszelnicka M; Fidyk W; Solarska I; Nasiłowska-Adamska B; Skowrońska P; Bieniaszewska M; Tomaszewska A; Basak GW; Giebel S; Wróbel T; Bogunia-Kubik K
    Front Immunol; 2023; 14():1227897. PubMed ID: 37901227
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MSH-5: malignant knee tumors timely detection index.
    Rivera-Saldívar G; Torres-González R; Cario-Méndez A; Técualt-Gómez R; Amaya-Zepeda RA; Alcántara-Corona A; Fuentes-Figueroa S
    Cir Cir; 2023; 91(2):146-152. PubMed ID: 37084299
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission.
    Konuma T; Kondo T; Masuko M; Shimizu H; Shiratori S; Fukuda T; Kato J; Sawa M; Ozawa Y; Ota S; Uchida N; Kanda Y; Kako S; Fujisawa S; Fukushima K; Ichinohe T; Atsuta Y; Yanada M;
    Bone Marrow Transplant; 2021 Nov; 56(11):2779-2787. PubMed ID: 34272486
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epidemiology of glucocorticoid-induced osteoporosis and management of associated fracture risk in Japan.
    Soen S; Kaku M; Okubo N; Touzeni S; Saito K; Kobayashi M
    J Bone Miner Metab; 2021 Nov; 39(6):1019-1030. PubMed ID: 34125296
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Incidental identification of inv(16)(p13.1q22)/
    Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Osteoradionecrosis of the sternoclavicular joint after laryngopharyngeal radiation.
    Irizarry R; Shatzkes DR; Teng S; Kohli N; Har-El G
    Laryngoscope; 2019 Apr; 129(4):865-870. PubMed ID: 30450587
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Abdominal Fat Graft for Sellar Reconstruction: Retrospective Outcomes Review and Technical Note.
    Roca E; Penn DL; Safain MG; Burke WT; Castlen JP; Laws ER
    Oper Neurosurg (Hagerstown); 2019 Jun; 16(6):667-674. PubMed ID: 30124966
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.
    Coleman R; Hall A; Albanell J; Hanby A; Bell R; Cameron D; Dodwell D; Marshall H; Jean-Mairet J; Tercero JC; Rojo F; Gregory W; Gomis RR
    Lancet Oncol; 2017 Nov; 18(11):1543-1552. PubMed ID: 29037984
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrated RNA-seq and DNase-seq analyses identify phenotype-specific BMP4 signaling in breast cancer.
    Ampuja M; Rantapero T; Rodriguez-Martinez A; Palmroth M; Alarmo EL; Nykter M; Kallioniemi A
    BMC Genomics; 2017 Jan; 18(1):68. PubMed ID: 28077088
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutational Profile of Metastatic Breast cancers: A Retrospective Analysis.
    Lefebvre C; Bachelot T; Filleron T; Pedrero M; Campone M; Soria JC; Massard C; Lévy C; Arnedos M; Lacroix-Triki M; Garrabey J; Boursin Y; Deloger M; Fu Y; Commo F; Scott V; Lacroix L; Dieci MV; Kamal M; Diéras V; Gonçalves A; Ferrerro JM; Romieu G; Vanlemmens L; Mouret Reynier MA; Théry JC; Le Du F; Guiu S; Dalenc F; Clapisson G; Bonnefoi H; Jimenez M; Le Tourneau C; André F
    PLoS Med; 2016 Dec; 13(12):e1002201. PubMed ID: 28027327
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma.
    Hung JJ; Yeh YC; Jeng WJ; Chien HC; Wu YC; Chou TY; Hsu WH
    J Thorac Oncol; 2015 Sep; 10(9):1328-1336. PubMed ID: 26291011
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
    Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
    Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
    Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
    Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
    Kanagal-Shamanna R; Zhao W; Vadhan-Raj S; Nguyen MH; Fernandez MH; Medeiros LJ; Bueso-Ramos CE
    Int J Environ Res Public Health; 2012 Aug; 9(8):2788-800. PubMed ID: 23066397
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Genotyping and minimal residual disease study in children with acute myeloid leukemia: preliminary results].
    Balwierz W; Pietrzyk JJ; Wator G; Stozek K; Klekawka T; Kwiecińska K; Dłuzniewska A; Matysiak M; Malinowska I; Sikorska-Fic B; Balcerska A; Maciejka-Kapuścińska L; Sońta-Jakimczyk D; Tomaszewska R; Chybicka A; Krawczuk-Rybak M; Muszyńska-Rosłan K; Młynarski W; Stolarska M; Urasiński T; Kamieńska E; Sobol G; Wieczorek M; Karolczyk G; Wysocki M; Kołtan S; Kowalczyk JR; Wójcik B; Ksiazek T; Szewczyk K
    Przegl Lek; 2010; 67(6):371-4. PubMed ID: 21344764
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Therapeutic effects of strontium-89 against osseous metastases of lung cancer: analysis of 126 cases].
    Zheng H; Luo RC; Fan YX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1194-6. PubMed ID: 15485798
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia.
    Nemecek ER; Gooley TA; Woolfrey AE; Carpenter PA; Matthews DC; Sanders JE
    Bone Marrow Transplant; 2004 Nov; 34(9):799-806. PubMed ID: 15361903
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.